ARTICLE | Clinical News
Nasal CO2: Phase II started
September 7, 2015 7:00 AM UTC
Capnia said investigators began an open-label, U.S. Phase II trial to evaluate 0.5 L/minute nasal CO2 given for 10 seconds in each nostril up to 6 times to treat 1 cluster headache attack in a 24-hour...